CIK 0001534133 · Non-accelerated filer<br>Smaller reporting company
CalciMedica, Inc.
Sign in to watch- Ticker
- CALC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 452120079
- Phone
- 858-952-5500
- Business address
- 505 COAST BOULEVARD SOUTH, SUITE 307, LA JOLLA, CA, 92037
- Former names
- CalciMedica, Inc. /DE/, GRAYBUG VISION, INC., GRAYBUG, Inc., GRAYBUG LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-19 | Guerard Frederic Chief Executive Officer | Option exercise · Restricted Stock Units | −112,500 | 337,500 | ||
| 2022-04-13 | Sauer Dirk Director | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2022-03-31 | BREUIL ROBERT S Chief Financial Officer | Option exercise | +5,000 | 22,717 | ||
| 2022-03-31 | BREUIL ROBERT S Chief Financial Officer | Sale | −2,188 | $1.25 | $3K | 20,529 |
| 2022-03-31 | BREUIL ROBERT S Chief Financial Officer | Option exercise · Restricted Stock Units | −5,000 | 50,000 | ||
| 2022-02-28 | Zamiri Parisa Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +63,845 | 63,845 | ||
| 2022-02-28 | Zamiri Parisa Chief Medical Officer | Grant or award · Restricted Stock Unit | +83,155 | 83,155 | ||
| 2022-02-28 | Guerard Frederic Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +170,054 | 170,054 | ||
| 2022-02-28 | Guerard Frederic Chief Executive Officer | Grant or award · Restricted Stock Unit | +221,746 | 221,746 | ||
| 2022-02-28 | BREUIL ROBERT S Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +63,845 | 63,845 | ||
| 2022-02-28 | BREUIL ROBERT S Chief Financial Officer | Grant or award · Restricted Stock Unit | +83,155 | 83,155 | ||
| 2021-12-04 | BREUIL ROBERT S Chief Financial Officer | Option exercise | +5,000 | 17,717 | ||
| 2021-12-04 | BREUIL ROBERT S Chief Financial Officer | Option exercise · Restricted Stock Units | −5,000 | 55,000 | ||
| 2021-09-22 | BREUIL ROBERT S Chief Financial Officer | Option exercise | +20,000 | 20,000 | ||
| 2021-09-22 | BREUIL ROBERT S Chief Financial Officer | Sale | −7,283 | $3.55 | $26K | 12,717 |
| 2021-09-22 | BREUIL ROBERT S Chief Financial Officer | Option exercise · Restricted Stock Units | −20,000 | 60,000 | ||
| 2021-06-02 | Cagle Gerald D. Director | Grant or award · Employee Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2021-06-02 | EASTLAND JULIA MARIE Director | Grant or award · Employee Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2021-06-02 | BJERKHOLT ERIC Director | Grant or award · Employee Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2021-06-02 | SHAFFER CHRISTY L Director | Grant or award · Employee Stock Option (Right to Buy) | +12,500 | 12,500 |
Page 26 of 29 · 565 trades